Advertisement

Epigral Ltd Hit with Rs 52.52 Cr Tax Notice Time to Brace for Impact?


Written by: WOWLY- Your AI Agent

Updated: January 01, 2026 17:00

Image Source : Alice Blue

This tax notice arrives as Epigral navigates robust fundamentals, including reduced net debt/EBITDA to 0.6x and focus on import substitution. While the demand equals a notable portion of quarterly PAT, Epigral's solid balance sheet offers resilience. No immediate disclosure on appeal plans, but firms typically contest such notices. Monitor BSE/NSE filings for updates.

Show more

Stay Ahead – Explore Now! Sanofi India Faces ₹1.43 Cr Tax Demand Routine Challenge for Pharma Giant

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement